Key facts
- It has raised $2.2M; the latest was Early Stage VC in Sep 2025.
- Notable investors include European Innovation Council, EIT Food, INNVIERTE SICC, Faber Ventures, ESADE Ramon Llull University — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for KOA Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for KOA Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About KOA Biotech
Developer of microbiological testing technology intended to reduce fish mortality from pathogenic infections. The company provides digital, autonomous, and onsite testing technology that consists of water samples shipped to labs, onsite testing kits that continually monitor potentially harmful bacteria in water and create early warning alerts to prevent infections, enabling fish farms to create more sustainable food production and improve disease management in aquaculture.
- Sector
- Materials and Resources
- HQ
- Barcelona, Spain
- Founded
- 2021
- Employees
- 15
- Website
- koabiotech.com/
- Ownership
- Privately Held (backing)
KOA Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in KOA Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on KOA Biotech in its N-PORT filings yet. We sweep new filings monthly.